Abstract
Abstract This article attempts to present the backdrop against which Medicare carriers are chartered to make local coverage decisions, and it provides a triangular paradigm for expressing the regulatory, collaborative and evaluative boundaries within which this decision-making takes place. Although infectious disease molecular diagnostic testing will be underscored, this model can be extrapolated to the full complement of Medicare policy issues.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
